abbvie glp-1 receptor agonists weight management diabetes treatments Pharmacology Consult: GLP-1 receptor agonists

Reduced caloric intake combined with new metabolic signaling can affect energy availability, recovery capacity, and blood sugar stability during intense workouts

p = 0.18

Semaglutide and Tirzepatide can help athletes shed excess body fat without compromising muscle gains

Dual GLP-1/glucagon receptor agonists, including mazdutide, integrate appetite suppression with increased energy expenditure and fat oxidation, while triple GLP-1/GIP/glucagon agonists, such as retatrutide, further augment these mechanisms through multi-pathway receptor engagement

Flatt and K

Liraglutide, marketed under the brand names Victoza for diabetes management and Saxenda for weight management, is a versatile GLP-1 receptor agonist with a distinct focus on weight loss